Published in Neurology on August 22, 2006
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Rapidly progressive dementia. Ann Neurol (2008) 3.00
Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol (2008) 2.80
A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology (2012) 2.66
Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology (2011) 2.42
Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol (2012) 2.18
Rapidly progressive neurodegenerative dementias. Arch Neurol (2009) 1.46
Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology (2012) 1.43
Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain (2008) 1.30
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain (2012) 1.24
Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol (2011) 1.24
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol (2009) 1.21
Cerebrospinal fluid markers in Creutzfeldt-Jakob disease. Cerebrospinal Fluid Res (2008) 1.17
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain (2009) 1.13
Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol (2007) 1.12
Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol (2010) 0.96
Biological fluid biomarkers in neurodegenerative parkinsonism. Nat Rev Neurol (2009) 0.96
Urinary alpha1-antichymotrypsin: a biomarker of prion infection. PLoS One (2008) 0.96
Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients. J Neurol (2009) 0.94
Tau as a biomarker of neurodegenerative diseases. Biomark Med (2008) 0.91
A proposal of new diagnostic pathway for fatal familial insomnia. J Neurol Neurosurg Psychiatry (2013) 0.87
Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders. PLoS One (2011) 0.87
Application of "omics" to prion biomarker discovery. J Biomed Biotechnol (2010) 0.86
High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease. BMC Neurol (2011) 0.85
The molecular epidemiology of variant CJD. Int J Mol Epidemiol Genet (2011) 0.84
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. Int J Mol Sci (2011) 0.84
Ethics in prion disease. Prog Neurobiol (2013) 0.83
MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease. J Neurol (2009) 0.82
Small-molecule theranostic probes: a promising future in neurodegenerative diseases. Int J Cell Biol (2013) 0.82
Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels. Neurosci Lett (2009) 0.81
A polymorphism in the regulatory region of PRNP is associated with increased risk of sporadic Creutzfeldt-Jakob disease. BMC Med Genet (2011) 0.81
Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD. J Neurol (2015) 0.80
Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease. Neurol Clin Pract (2015) 0.80
PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2. Prion (2013) 0.80
Pathologic evidence that the T188R mutation in PRNP is associated with prion disease. J Neuropathol Exp Neurol (2010) 0.80
Diagnostic and Prognostic Value of Human Prion Detection in Cerebrospinal Fluid. Ann Neurol (2016) 0.80
Clinical findings and diagnosis in genetic prion diseases in Germany. Eur J Epidemiol (2015) 0.79
Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt-Jakob disease: an evidence-based approach. CMAJ (2014) 0.78
Prion Diseases. Continuum (Minneap Minn) (2015) 0.78
Subacute progressive aphasia: a rare presentation of Creutzfeldt-Jakob disease. J Neurol (2016) 0.78
No evidence for association between tau gene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease. BMC Med Genet (2007) 0.77
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants. J Alzheimers Dis (2016) 0.76
The use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and research. Psychiatr Clin North Am (2015) 0.76
Unusual features of Creutzfeldt-Jakob disease followed-up in a memory clinic. J Neurol (2014) 0.76
Genomic and post-genomic analyses of human prion diseases. Genome Med (2009) 0.76
Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases. BMC Neurol (2015) 0.75
Biomarkers for sporadic Creutzfeldt-Jakob disease. Ann Clin Transl Neurol (2016) 0.75
An Interplay of S-Nitrosylation and Metal Ion Binding for Astrocytic S100B Protein. PLoS One (2016) 0.75
Diagnosing sporadic creutzfeldt-jakob disease in a patient with a suspected status epilepticus in the intensive care unit. Case Rep Neurol Med (2013) 0.75
Infectious disease - developments in the field of Creutzfeldt-Jakob disease. Rev Neurol Dis (2007) 0.75
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels. Acta Neuropathol (2017) 0.75
Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients. Aging (Albany NY) (2016) 0.75
CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result. J Neurol (2016) 0.75
Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia. Front Aging Neurosci (2017) 0.75
Three sporadic cases of Creutzfeldt-Jakob disease in China and their clinical analysis. Exp Ther Med (2017) 0.75
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg (2001) 11.58
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess (2007) 6.55
Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature (1998) 5.59
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest (2000) 5.07
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
The influence of patient-practitioner agreement on outcome of care. Am J Public Health (1981) 4.08
Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst (1989) 3.48
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet (1998) 3.26
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
Ratings of profile attractiveness after functional appliance treatment. Am J Orthod Dentofacial Orthop (2000) 3.20
Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support. Tob Control (2009) 3.05
Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology (2000) 3.03
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med (1987) 2.98
Creutzfeldt-Jakob disease and blood transfusion. Lancet (1993) 2.97
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol (2004) 2.95
The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet (2000) 2.92
Gestational diabetes mellitus in India. J Assoc Physicians India (2004) 2.86
Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia (2012) 2.85
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.63
Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science (1990) 2.56
Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (1999) 2.55
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain (2006) 2.54
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
The importance of list size and consultation length as factors in general practice. J R Coll Gen Pract (1987) 2.49
Familiarity with and social distance from people who have serious mental illness. Psychiatr Serv (2001) 2.47
Buteyko breathing techniques in asthma: a blinded randomised controlled trial. Med J Aust (1999) 2.42
Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet (1992) 2.40
Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ (1995) 2.40
Characterization of the mRNA for herpes simplex virus thymidine kinase by cell-free synthesis of active enzyme. Nucleic Acids Res (1978) 2.40
A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene (2006) 2.37
Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.36
Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol (1998) 2.35
Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain (2001) 2.34
Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979-96: retrospective examination of clinical records. BMJ (2000) 2.32
Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol (1998) 2.31
Genome-wide association scan for five major dimensions of personality. Mol Psychiatry (2008) 2.29
Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology (2008) 2.27
Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med (2001) 2.26
Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet (1998) 2.26
Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess (1997) 2.20
Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med (1999) 2.19
In vitro evaluation of tobramycin, a new aminoglycoside antibiotic. Antimicrob Agents Chemother (1972) 2.18
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology (2004) 2.15
Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ (1998) 2.15
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab (1999) 2.13
N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest (2000) 2.13
Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature (1992) 2.11
Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis. Int J Tuberc Lung Dis (2013) 2.11
The importance of genes and environment for ocular refraction and its determiners: a population based study among 20-45 year old twins. Br J Ophthalmol (2001) 2.09
The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab (1995) 2.07
Cause of death and correlation with autopsy findings in burns patients. Burns (2012) 2.07
Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia (1981) 2.06
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology (2002) 2.05
[Familial forms of fronto-temporal dementia]. Ned Tijdschr Geneeskd (1995) 2.04
Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma. Radiother Oncol (1996) 2.03
Health sector reform and the interpretation of policy context. Health Policy (1999) 2.00
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology (2007) 2.00
Analysis of relapses in anti-NMDAR encephalitis. Neurology (2011) 1.98
Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand (1980) 1.98
Further evidence for an association between genetic variation in transforming growth factor alpha and cleft lip and palate. Am J Hum Genet (1991) 1.98
Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol (1998) 1.98
Meta-analysis of genome-wide association studies for personality. Mol Psychiatry (2010) 1.96
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut (2002) 1.96
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
Prejudice, social distance, and familiarity with mental illness. Schizophr Bull (2001) 1.95
Nail patella syndrome: a review of the phenotype aided by developmental biology. J Med Genet (2003) 1.95
Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry (2007) 1.93
ACE polymorphisms. Circ Res (2006) 1.92
Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet (1996) 1.91
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci (2003) 1.90
Power of selective genotyping in genetic association analyses of quantitative traits. Behav Genet (2000) 1.89
In vitro suppression of UAG and UGA mutants in the thymidine kinase gene of herpes simplex virus. Proc Natl Acad Sci U S A (1979) 1.88
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology (2005) 1.88
Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry (1988) 1.87
High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet (1999) 1.87
Octapeptide repeat insertions in the prion protein gene and early onset dementia. J Neurol Neurosurg Psychiatry (2004) 1.87
How much residual plasma may cause TRALI? Transfus Med (2008) 1.85
Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Biochem J (2000) 1.84
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet (2001) 1.83
Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology (2000) 1.82